Clinical Trial Update: Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating sputum cytometry for lung cancer screening after asbestos exposure; no results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University Hospital, Caen | Conditions: Lung Neoplasms | Phase 3 | Status: UNKNOWN